Newbury Street Acquisition Corp. operates as a blank check company. The company is headquartered in Boston, Massachusetts. The company went IPO on 2021-03-23. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The firm intends to focus on a technology business in the consumer Internet or media space. The firm is not engaged in any business operations and has not generated any revenue.
最新の財務諸表(Form-10K)によると、Newbury Street Acquisition Corpの総資産は$22で、純損失は$0です。
NBSTの主要な財務比率は何ですか?
Newbury Street Acquisition Corpの流動比率は3.66、純利益率は0、1株当たり売上高は$0です。
Newbury Street Acquisition Corpの収益はセグメントまたは地域別にどのように分けられていますか?
Newbury Street Acquisition Corp の最大収益セグメントは Ampligen and Other Drugs で、最新の利益発表における収益は 170,000 です。地域別に見ると、United States が Newbury Street Acquisition Corp の主要市場であり、収益は 170,000 です。
Newbury Street Acquisition Corpは収益を上げていますか?
いいえ、最新の財務諸表によると、Newbury Street Acquisition Corpの純損失は$0です。